Prevalence of Antipsychotic Use in Long-Term Care Residents with Parkinson Dementia

Geriatric Nursing

Volumn 33, Issue 3, 2012, Pages 217-219

  Zarowitz, Barbara J ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; DEMENTIA; HUMAN; LONG TERM CARE; NURSING HOME; ORGANIZATION AND MANAGEMENT; PARKINSON DISEASE;

ANTIPSYCHOTIC AGENTS; DEMENTIA; HUMANS; LONG-TERM CARE; NURSING HOMES; PARKINSON DISEASE;

EID: 84861694690     PISSN: 01974572     EISSN: 15283984     Source Type: Journal    
DOI: 10.1016/j.gerinurse.2012.03.006     Document Type: Article

References (9)

1. American Medical Directors Association Parkinson Disease Clinical Practice Guideline. American Medical Directors Association; 2010.
2. Lapane K.L., Fernandez H.H., Friedman J.H. Prevalence, clinical characteristics and pharmacological treatment of Parkinson disease in residents in long-term care facilities. Pharmacotherapy 1999, 19:1321-1327.
3. McKeith I., Mintzer J., Aarsland E., et al. Dementia with Lewy bodies. The Lancet 2004, 3:19-28.
4. Zarowitz BJ, O'Shea T. Profile of patients with Parkinson disease in long-term care facilities: prevalence, clinical characteristics and pharmacological treatment. Senior Health Outcomes, Omnicare, Inc. Data on file, 2011.
5. Miyasaki J.M., Shannon K., Voon V., et al. Practice parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006, 66:996-1002.
6. Marras C., Gruneir A., Wang X., et al. Antipsychotics and mortality in Parkinsonism. Am J Geriatr Psych 2012, 20:149-158.
7. Psychosis: Antipsychotic agents. Geriatric Pharmaceutical Care Guidelines. Covington, KY: Omnicare, Inc. Available at Cited March 22, 2012. http://gpcg.omnicare.com.
8. Ravina B., Putt M., Siderowf A., et al. Donepezil for dementia in Parkinson's disease: a randomized, double-blind, placebo controlled, crossover study. J Neurol Neurosurg Psychiatry 2005, 76:934-939.
9. Emre M., Aarsland D., Albanese A., et al. Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med 2004, 351:2509-2518.